Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India. [3]
The Pharmacy Council of India (PCI) is the statutory body under the Ministry of Health and Family Welfare, Government of India. It is constituted under the Pharmacy Act of 1948. [1] The Council was first constituted on 4 March 1948. [2] Montubhai Patel was elected as the new president of PCI in May 2022. [3] [4]
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices.It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union.
The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India. [1] National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29 August 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent ...
National Institute of Pharmaceutical Education and Research (NIPERs) are a group of national level institutes of pharmaceutical sciences or Pharmacy school in India. The Government of India has declared the NIPERs as Institutes of National Importance.
Pages in category "Pharmaceutical companies of India" The following 65 pages are in this category, out of 65 total. ... Indian Drugs and Pharmaceuticals; Intas ...
Pharmaceutical exports from Gujarat, India have increased by 11% in fiscal year 2018–19, according to data provided by the Gujarat State Board of Indian Drug Manufacturers’ Association (IDMA). Gujarat accounts for a minimum of 28% of India's pharma exports, with exports totalling $5.36bn in 2018–19, up from $4.83bn the previous year.